1 |
Costa KM, Saxena AK. Surgical chylothorax in neonates: management and outcomes. World J Pediatr 2018;14:110-5.
DOI
|
2 |
Schild HH, Naehle CP, Wilhelm KE, et al. Lymphatic interventions for treatment of chylothorax. Rofo 2015;187:584-8.
DOI
|
3 |
Mierzejewski M, Korczynski P, Krenke R, Janssen JP. Chemical pleurodesis: a review of mechanisms involved in pleural space obliteration. Respir Res 2019;20:247.
DOI
|
4 |
Lee YG, Jung I, Koo DH, et al. Efficacy and safety of Viscum album extract (Helixor-M) to treat malignant pleural effusion in patients with lung cancer. Support Care Cancer 2019;27:1945-9.
DOI
|
5 |
Cho HJ, Na KJ, Kim DW, Choi YE, Ma JS, Jeong IS. Chemical pleurodesis using a Viscum album extract in infants with congenital chylothorax. Eur J Pediatr 2014;173:823-6.
DOI
|
6 |
Aljazairi AS, Bhuiyan TA, Alwadai AH, Almehizia RA. Octreotide use in post-cardiac surgery chylothorax: a 12-year perspective. Asian Cardiovasc Thorac Ann 2017;25:6-12.
DOI
|
7 |
Kienle GS, Kiene H. Review article: influence of Viscum album L (European mistletoe) extracts on quality of life in cancer patients: a systematic review of controlled clinical studies. Integr Cancer Ther 2010;9:142-57.
DOI
|
8 |
Rosti L, De Battisti F, Butera G, et al. Octreotide in the management of postoperative chylothorax. Pediatr Cardiol 2005;26:440-3.
DOI
|
9 |
Mery CM, Moffett BS, Khan MS, et al. Incidence and treatment of chylothorax after cardiac surgery in children: analysis of a large multi-institution database. J Thorac Cardiovasc Surg 2014;147:678-86.
DOI
|
10 |
Biewer ES, Zurn C, Arnold R, et al. Chylothorax after surgery on congenital heart disease in newborns and infants: risk factors and efficacy of MCT-diet. J Cardiothorac Surg 2010;5:127.
DOI
|